FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029488857> ?p ?o ?g. }

• W2029488857 endingPage "371" @default.
• W2029488857 startingPage "365" @default.
• W2029488857 abstract "It remains unclear whether there are differences in the safety and efficacy outcomes between everolimus-eluting stents (EES) and sirolimus-eluting stents (SES) in contemporary practice.We prospectively enrolled 6166 consecutive patients who received EES (3081 patients) and SES (3085 patients) between April 2008 and June 2010, using data from the Interventional Cardiology Research In-Cooperation Society-Drug-Eluting Stents Registry. The primary end point was a composite of death, nonfatal myocardial infarction (MI), or target-vessel revascularization (TVR). At 2 years of follow-up, the 2 study groups did not differ significantly in crude risk of the primary end point (12.1% for EES versus 12.4% for SES; HR, 0.97; 95% CI, 0.84-1.12, P=0.66). After adjustment for differences in baseline risk factors, the adjusted risk for the primary end point remained similar for the 2 stent types (HR, 0.96; 95% CI, 0.82-1.12, P=0.60). There were also no differences between the stent groups in the adjusted risks of the individual component of death (HR, 0.93; 95% CI, 0.67-1.30, P=0.68), MI (HR, 0.97; 95% CI, 0.79-1.18, P=0.74), and TVR (HR, 1.10; 95% CI, 0.82-1.49, P=0.51). The adjusted risk of stent thrombosis also was similar (HR, 1.16; 95% CI, 0.47-2.84, P=0.75).In contemporary practice of percutaneous coronary intervention procedures, the unrestricted use of EES and SES showed similar rates of safety and efficacy outcomes with regard to death, MI, sent thrombosis, and TVR. Future longer-term follow-up is needed to better define the relative benefits of these drug-eluting stents.URL: http://www.clinicaltrials.gov. Unique identifier: NCT01070420." @default.
• W2029488857 created "2016-06-24" @default.
• W2029488857 creator A5002116531 @default.
• W2029488857 creator A5002439880 @default.
• W2029488857 creator A5006351284 @default.
• W2029488857 creator A5016847290 @default.
• W2029488857 creator A5018137504 @default.
• W2029488857 creator A5022918839 @default.
• W2029488857 creator A5023630898 @default.
• W2029488857 creator A5033342453 @default.
• W2029488857 creator A5034392525 @default.
• W2029488857 creator A5037058160 @default.
• W2029488857 creator A5037475150 @default.
• W2029488857 creator A5037864368 @default.
• W2029488857 creator A5039106969 @default.
• W2029488857 creator A5039373086 @default.
• W2029488857 creator A5040178735 @default.
• W2029488857 creator A5042646691 @default.
• W2029488857 creator A5043741166 @default.
• W2029488857 creator A5045678305 @default.
• W2029488857 creator A5048764382 @default.
• W2029488857 creator A5060749155 @default.
• W2029488857 creator A5064162161 @default.
• W2029488857 creator A5067591497 @default.
• W2029488857 creator A5073512860 @default.
• W2029488857 creator A5074569963 @default.
• W2029488857 creator A5074893722 @default.
• W2029488857 creator A5075982874 @default.
• W2029488857 creator A5076041223 @default.
• W2029488857 creator A5079150146 @default.
• W2029488857 creator A5081036674 @default.
• W2029488857 creator A5081603863 @default.
• W2029488857 creator A5086873475 @default.
• W2029488857 creator A5087846202 @default.
• W2029488857 creator A5088687856 @default.
• W2029488857 creator A5090487149 @default.
• W2029488857 creator A5091569974 @default.
• W2029488857 creator A5091785709 @default.
• W2029488857 date "2012-06-01" @default.
• W2029488857 modified "2023-10-18" @default.
• W2029488857 title "Outcomes After Unrestricted Use of Everolimus-Eluting and Sirolimus-Eluting Stents in Routine Clinical Practice" @default.
• W2029488857 cites W1795635013 @default.
• W2029488857 cites W1893746779 @default.
• W2029488857 cites W1971428935 @default.
• W2029488857 cites W1997207240 @default.
• W2029488857 cites W2005726649 @default.
• W2029488857 cites W2009187570 @default.
• W2029488857 cites W2009589924 @default.
• W2029488857 cites W2027826776 @default.
• W2029488857 cites W2040113464 @default.
• W2029488857 cites W20404472 @default.
• W2029488857 cites W2047862780 @default.
• W2029488857 cites W2060153501 @default.
• W2029488857 cites W2105332661 @default.
• W2029488857 cites W2121956076 @default.
• W2029488857 cites W2125716797 @default.
• W2029488857 cites W2126830306 @default.
• W2029488857 cites W2141165366 @default.
• W2029488857 cites W2144860230 @default.
• W2029488857 cites W2146743728 @default.
• W2029488857 cites W2547342372 @default.
• W2029488857 cites W80935715 @default.
• W2029488857 cites W81997084 @default.
• W2029488857 doi "https://doi.org/10.1161/circinterventions.111.966549" @default.
• W2029488857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22693347" @default.
• W2029488857 hasPublicationYear "2012" @default.
• W2029488857 type Work @default.
• W2029488857 sameAs 2029488857 @default.
• W2029488857 citedByCount "37" @default.
• W2029488857 countsByYear W20294888572012 @default.
• W2029488857 countsByYear W20294888572013 @default.
• W2029488857 countsByYear W20294888572014 @default.
• W2029488857 countsByYear W20294888572016 @default.
• W2029488857 countsByYear W20294888572017 @default.
• W2029488857 countsByYear W20294888572018 @default.
• W2029488857 countsByYear W20294888572019 @default.
• W2029488857 countsByYear W20294888572020 @default.
• W2029488857 countsByYear W20294888572021 @default.
• W2029488857 countsByYear W20294888572022 @default.
• W2029488857 crossrefType "journal-article" @default.
• W2029488857 hasAuthorship W2029488857A5002116531 @default.
• W2029488857 hasAuthorship W2029488857A5002439880 @default.
• W2029488857 hasAuthorship W2029488857A5006351284 @default.
• W2029488857 hasAuthorship W2029488857A5016847290 @default.
• W2029488857 hasAuthorship W2029488857A5018137504 @default.
• W2029488857 hasAuthorship W2029488857A5022918839 @default.
• W2029488857 hasAuthorship W2029488857A5023630898 @default.
• W2029488857 hasAuthorship W2029488857A5033342453 @default.
• W2029488857 hasAuthorship W2029488857A5034392525 @default.
• W2029488857 hasAuthorship W2029488857A5037058160 @default.
• W2029488857 hasAuthorship W2029488857A5037475150 @default.
• W2029488857 hasAuthorship W2029488857A5037864368 @default.
• W2029488857 hasAuthorship W2029488857A5039106969 @default.
• W2029488857 hasAuthorship W2029488857A5039373086 @default.
• W2029488857 hasAuthorship W2029488857A5040178735 @default.
• W2029488857 hasAuthorship W2029488857A5042646691 @default.
• W2029488857 hasAuthorship W2029488857A5043741166 @default.
• W2029488857 hasAuthorship W2029488857A5045678305 @default.

• next